JOSEPH J LAROSA Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH J LAROSA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of JOSEPH J LAROSA for April 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 18,311 | |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 6,622 | 392,022 | 23,311 | |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 29,933 | |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 573.59 | 577 | 330,961 | 14,438 | 15 K to 14.4 K (-3.84 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 572.94 | 61 | 34,949 | 15,015 | 15.1 K to 15 K (-0.40 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 571.65 | 112 | 64,025 | 15,076 | 15.2 K to 15.1 K (-0.74 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 570.27 | 125 | 71,284 | 15,188 | 15.3 K to 15.2 K (-0.82 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 569.41 | 234 | 133,242 | 15,313 | 15.5 K to 15.3 K (-1.51 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 567.30 | 669 | 379,524 | 15,547 | 16.2 K to 15.5 K (-4.13 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 566.44 | 1,189 | 673,497 | 16,216 | 17.4 K to 16.2 K (-6.83 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 565.60 | 1,468 | 830,301 | 17,405 | 18.9 K to 17.4 K (-7.78 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 564.74 | 377 | 212,907 | 18,873 | 19.3 K to 18.9 K (-1.96 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 563.58 | 416 | 234,449 | 19,250 | 19.7 K to 19.3 K (-2.12 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 562.71 | 21 | 11,817 | 19,666 | 19.7 K to 19.7 K (-0.11 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 561.57 | 51 | 28,640 | 19,687 | 19.7 K to 19.7 K (-0.26 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 18,311 | |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 555.82 | 2,720 | 1,511,830 | 19,738 | 22.5 K to 19.7 K (-12.11 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 6,622 | 392,022 | 23,311 | |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 22,458 | 17.5 K to 22.5 K (+28.64 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 29,933 | |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 555.82 | 3,602 | 2,002,064 | 17,458 | 21.1 K to 17.5 K (-17.10 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 573.59 | 577 | 330,961 | 14,438 | 15 K to 14.4 K (-3.84 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 6,622 | 392,022 | 21,060 | 14.4 K to 21.1 K (+45.87 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 572.94 | 61 | 34,949 | 15,015 | 15.1 K to 15 K (-0.40 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 565.92 | 94 | 53,196 | 14,438 | 14.5 K to 14.4 K (-0.65 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 571.65 | 112 | 64,025 | 15,076 | 15.2 K to 15.1 K (-0.74 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 564.19 | 93 | 52,470 | 14,532 | 14.6 K to 14.5 K (-0.64 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 570.27 | 125 | 71,284 | 15,188 | 15.3 K to 15.2 K (-0.82 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 563.39 | 171 | 96,340 | 14,625 | 14.8 K to 14.6 K (-1.16 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 569.41 | 234 | 133,242 | 15,313 | 15.5 K to 15.3 K (-1.51 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 562.56 | 191 | 107,449 | 14,796 | 15 K to 14.8 K (-1.27 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 567.30 | 669 | 379,524 | 15,547 | 16.2 K to 15.5 K (-4.13 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 561.76 | 63 | 35,391 | 14,987 | 15.1 K to 15 K (-0.42 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 566.44 | 1,189 | 673,497 | 16,216 | 17.4 K to 16.2 K (-6.83 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 560.38 | 163 | 91,342 | 15,050 | 15.2 K to 15.1 K (-1.07 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 565.60 | 1,468 | 830,301 | 17,405 | 18.9 K to 17.4 K (-7.78 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 559.79 | 285 | 159,540 | 15,213 | 15.5 K to 15.2 K (-1.84 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 564.74 | 377 | 212,907 | 18,873 | 19.3 K to 18.9 K (-1.96 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 558.55 | 293 | 163,655 | 15,498 | 15.8 K to 15.5 K (-1.86 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 563.58 | 416 | 234,449 | 19,250 | 19.7 K to 19.3 K (-2.12 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 557.40 | 93 | 51,838 | 15,791 | 15.9 K to 15.8 K (-0.59 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 562.71 | 21 | 11,817 | 19,666 | 19.7 K to 19.7 K (-0.11 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 556.51 | 198 | 110,189 | 15,884 | 16.1 K to 15.9 K (-1.23 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 561.57 | 51 | 28,640 | 19,687 | 19.7 K to 19.7 K (-0.26 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 555.10 | 114 | 63,281 | 16,082 | 16.2 K to 16.1 K (-0.70 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 555.82 | 2,720 | 1,511,830 | 19,738 | 22.5 K to 19.7 K (-12.11 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 552.85 | 104 | 57,496 | 16,196 | 16.3 K to 16.2 K (-0.64 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 22,458 | 17.5 K to 22.5 K (+28.64 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 550.00 | 6 | 3,300 | 16,300 | 16.3 K to 16.3 K (-0.04 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 555.82 | 3,602 | 2,002,064 | 17,458 | 21.1 K to 17.5 K (-17.10 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 549.24 | 100 | 54,924 | 16,306 | 16.4 K to 16.3 K (-0.61 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 6,622 | 392,022 | 21,060 | 14.4 K to 21.1 K (+45.87 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 548.27 | 99 | 54,279 | 16,406 | 16.5 K to 16.4 K (-0.60 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 565.92 | 94 | 53,196 | 14,438 | 14.5 K to 14.4 K (-0.65 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 547.00 | 100 | 54,700 | 16,505 | 16.6 K to 16.5 K (-0.60 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 564.19 | 93 | 52,470 | 14,532 | 14.6 K to 14.5 K (-0.64 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 542.31 | 5 | 2,712 | 16,605 | 16.6 K to 16.6 K (-0.03 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 563.39 | 171 | 96,340 | 14,625 | 14.8 K to 14.6 K (-1.16 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 541.94 | 95 | 51,484 | 16,610 | 16.7 K to 16.6 K (-0.57 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 562.56 | 191 | 107,449 | 14,796 | 15 K to 14.8 K (-1.27 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 529.79 | 2,733 | 1,447,916 | 16,705 | 19.4 K to 16.7 K (-14.06 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 561.76 | 63 | 35,391 | 14,987 | 15.1 K to 15 K (-0.42 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 19,438 | 14.4 K to 19.4 K (+34.63 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 560.38 | 163 | 91,342 | 15,050 | 15.2 K to 15.1 K (-1.07 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 559.79 | 285 | 159,540 | 15,213 | 15.5 K to 15.2 K (-1.84 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 558.55 | 293 | 163,655 | 15,498 | 15.8 K to 15.5 K (-1.86 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 557.40 | 93 | 51,838 | 15,791 | 15.9 K to 15.8 K (-0.59 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 556.51 | 198 | 110,189 | 15,884 | 16.1 K to 15.9 K (-1.23 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 555.10 | 114 | 63,281 | 16,082 | 16.2 K to 16.1 K (-0.70 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 552.85 | 104 | 57,496 | 16,196 | 16.3 K to 16.2 K (-0.64 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 550.00 | 6 | 3,300 | 16,300 | 16.3 K to 16.3 K (-0.04 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 549.24 | 100 | 54,924 | 16,306 | 16.4 K to 16.3 K (-0.61 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 548.27 | 99 | 54,279 | 16,406 | 16.5 K to 16.4 K (-0.60 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 547.00 | 100 | 54,700 | 16,505 | 16.6 K to 16.5 K (-0.60 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 542.31 | 5 | 2,712 | 16,605 | 16.6 K to 16.6 K (-0.03 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 541.94 | 95 | 51,484 | 16,610 | 16.7 K to 16.6 K (-0.57 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 529.79 | 2,733 | 1,447,916 | 16,705 | 19.4 K to 16.7 K (-14.06 %) |
Apr 20 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 19,438 | 14.4 K to 19.4 K (+34.63 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 34,933 | |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 525.30 | 6 | 3,152 | 14,438 | 14.4 K to 14.4 K (-0.04 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 524.99 | 106 | 55,649 | 14,444 | 14.6 K to 14.4 K (-0.73 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 521.05 | 113 | 58,879 | 14,550 | 14.7 K to 14.6 K (-0.77 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 520.45 | 220 | 114,499 | 14,663 | 14.9 K to 14.7 K (-1.48 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 519.43 | 286 | 148,557 | 14,883 | 15.2 K to 14.9 K (-1.89 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 518.25 | 499 | 258,607 | 15,169 | 15.7 K to 15.2 K (-3.18 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 517.40 | 266 | 137,628 | 15,668 | 15.9 K to 15.7 K (-1.67 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 516.81 | 260 | 134,371 | 15,934 | 16.2 K to 15.9 K (-1.61 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 515.70 | 414 | 213,500 | 16,194 | 16.6 K to 16.2 K (-2.49 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 514.63 | 92 | 47,346 | 16,608 | 16.7 K to 16.6 K (-0.55 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 521.45 | 2,738 | 1,427,730 | 16,700 | 19.4 K to 16.7 K (-14.09 %) |
Apr 16 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 19,438 | 14.4 K to 19.4 K (+34.63 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 39,933 | |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 44,933 | |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 59.20 | 5,000 | 296,000 | 49,933 | |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 497.32 | 100 | 49,732 | 14,438 | 14.5 K to 14.4 K (-0.69 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 496.50 | 210 | 104,265 | 14,538 | 14.7 K to 14.5 K (-1.42 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 495.19 | 321 | 158,956 | 14,748 | 15.1 K to 14.7 K (-2.13 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 494.36 | 111 | 54,874 | 15,069 | 15.2 K to 15.1 K (-0.73 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 493.35 | 652 | 321,664 | 15,180 | 15.8 K to 15.2 K (-4.12 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 492.62 | 521 | 256,655 | 15,832 | 16.4 K to 15.8 K (-3.19 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 491.42 | 450 | 221,139 | 16,353 | 16.8 K to 16.4 K (-2.68 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 490.32 | 484 | 237,315 | 16,803 | 17.3 K to 16.8 K (-2.80 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 489.72 | 734 | 359,454 | 17,287 | 18 K to 17.3 K (-4.07 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 488.26 | 1,626 | 793,911 | 18,021 | 19.6 K to 18 K (-8.28 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 487.71 | 470 | 229,224 | 19,647 | 20.1 K to 19.6 K (-2.34 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 486.61 | 485 | 236,006 | 20,117 | 20.6 K to 20.1 K (-2.35 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 485.65 | 441 | 214,172 | 20,602 | 21 K to 20.6 K (-2.10 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 484.58 | 192 | 93,039 | 21,043 | 21.2 K to 21 K (-0.90 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 488.22 | 2,689 | 1,312,824 | 21,235 | 23.9 K to 21.2 K (-11.24 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 23,924 | 18.9 K to 23.9 K (+26.42 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 488.22 | 2,757 | 1,346,023 | 18,924 | 21.7 K to 18.9 K (-12.72 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 21,681 | 16.7 K to 21.7 K (+29.97 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 488.22 | 2,757 | 1,346,023 | 16,681 | 19.4 K to 16.7 K (-14.18 %) |
Apr 03 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 59.20 | 5,000 | 296,000 | 19,438 | 14.4 K to 19.4 K (+34.63 %) |